Suche

9766 Treffer – Seite 717 von 814

Integrating Risk of Treatment Inertia and Procedure to Guide Individualized Therapy in Tricuspid Regurgitation

Impact of coronary lesion complexity in octo- and nonagenarian all-comer patients undergoing percutaneous coronary intervention: Results from the prospective multicenter Cruz Senior Trial

Impact of high-bleeding risk and frailty on clinical and patient-reported outcomes in Octo- and Nonagenerians undergoing PCI – Insights from the prospective, multicenter Cruz Senior Trial

High-sensitivity C-reactive protein in patients with suspected myocardial infarction classified to the observe zone

Utilization Patterns for Antiplatelet Therapy after Acute Myocardial Infarction in Clinical Practice: A Comparison between Germany and the United States

Association Between low-grade Inflammation and Left-Ventricular Longitudinal Strain in Heart Failure and HFpEF Phenotypes

SGLT2 Inhibitors Are Associated with Improved Long-Term Survival in Takotsubo Syndrome: Insights from Large-Scale Real-World Data

Right ventricular hypercontractility is associated with long-term mortality in patients with heart failure with preserved ejection fraction

Rare Pathogenic Cardiomyopathy Variants and Risk of Cardiovascular Events in Five Large TIMI Outcome Trials

Vorhersagbarkeit thermischer Ösophagusläsionen bei Radiofrequenzablation von Vorhofflimmern unter Verwendung einer Ösophagus-Temperatursonde

Left Atrial Appendage Occlusion Confers Superior Net Clinical Benefit Over Oral Anticoagulation in Cirrhotic Patients With Atrial Fibrillation: A Real-World Propensity-Matched Study

Propensity matched Comparison of Pulsed-Field and Cryoballoon Ablation in Symptomatic Atrial Fibrillation Patients Undergoing Initial Pulmonary Vein Isolation

1
...
710
711
712
713
714
715
716
717
718
719
720
730
740
750
760
770
780
790
800
...
814

Das Portal für Herzmedizin und Herzgesundheit.

Betrieben von der HKM - Herz-Kreislauf-Medizin gGmbH

*Jeder Förderer unterstützt Herzmedizin.de mit 150.000 Euro jährlich. Die Förderer haben keinerlei Einfluss auf die Themengestaltung und die redaktionellen Inhalte des Portals.